This isn’t just a puff piece. There is a process in the release today that took a significant amount of time to research and analyse. It is also lead by one of the most respected in the field being Dr Blaskovich.
This research also extends the ability of btx1801 into that gram negative territory which we once thought was out of reach. It brings a whole new ball game to the antibiotic side.
Heres hoping these trial results are successful.. as if so with the further extension of our IP and research I think the 50 cent target is quite conservative with what we now know.
Bring it home Vinnie and Callahan!
BOT Price at posting:
14.5¢ Sentiment: Buy Disclosure: Held
(20min delay)